You won’t be shocked to learn that it is merely a cream made CBD oil extracted from the cannabis plant. The oil is blended with a variety of ingredients to create a CBD cream you can use for pain. If you take a look at the ointment of high-quality CBD suppliers such as PureKana, you’ll notice that the cream has a host of additional ingredients along with CBD.
Our Cannabidiol-infused Pain Freeze can help ease muscle aches and soreness. Working with your body’s Endocannabinoid System, or ECS, our CBD Pain Rub influences natural cannabinoids within your body to decrease muscle inflammation and tension. The body’s ECS is made up of cannabinoid receptors that respond to pain sensations. When our CBD Pain Gel is applied, it activates cannabinoid receptors to help regulate muscle aches and cramps.
One of CBD’s chief properties is its anticonvulsant nature. Clinical trials have shown that CBD is effective at reducing seizures in children, and the FDA is likely to approve Epidiolex, a pharmaceutical-grade version of CBD for this use, in summer 2018. Although CBD has been documented as an antiepileptic since 1881, CBD’s anticonvulsant mechanisms still remain unclear. Not enough studies have been conducted to understand this relationship fully. One possible explanation for CBD’s neuroprotective effects is its interaction with NMDA receptors, which play a key role in the overly active neuron activity that is a hallmark of epilepsy.
Stephanie Kahn, who with her husband, Jeffrey, runs the Takoma Wellness Center, a medical marijuana dispensary in Northwest Washington, says that about half of her 1,200 patients use CBD-rich products. Her dispensary offers several strains of high-CBD cannabis as well as CBD oil, with different ratios of CBD and THC, each of which she recommends for particular conditions. “We get questions about it every day,” she says. “A lot of our patients get relief with this, and a lot of times this works better than pharmaceutical drugs.”
Everything you need to know about CBD oil CBD oil may offer a range of benefits, including reducing pain and inflammation. Evidence shows that the oil does not contain psychoactive properties and so does not have the same effects as marijuana. Here, learn more about CBD oil and its uses, benefits, and risks. We also discuss its legality in the U.S. Read now
CBD does not appear to have any psychotropic ("high") effects such as those caused by ∆9-THC in marijuana, but may have anti-anxiety and anti-psychotic effects. As the legal landscape and understanding about the differences in medical cannabinoids unfolds, experts are working to distinguish "medical marijuana" (with varying degrees of psychotropic effects and deficits in executive function) – from "medical CBD therapies” which would commonly present as having a reduced or non-psychoactive side-effect profile.
Karl W. Hillig, a graduate student in the laboratory of long-time Cannabis researcher Paul G. Mahlberg at Indiana University, conducted a systematic investigation of genetic, morphological, and chemotaxonomic variation among 157 Cannabis accessions of known geographic origin, including fiber, drug, and feral populations. In 2004, Hillig and Mahlberg published a chemotaxonomic analysis of cannabinoid variation in their Cannabis germplasm collection. They used gas chromatography to determine cannabinoid content and to infer allele frequencies of the gene that controls CBD and THC production within the studied populations, and concluded that the patterns of cannabinoid variation support recognition of C. sativa and C. indica as separate species, but not C. ruderalis. The authors assigned fiber/seed landraces and feral populations from Europe, Central Asia, and Turkey to C. sativa. Narrow-leaflet and wide-leaflet drug accessions, southern and eastern Asian hemp accessions, and feral Himalayan populations were assigned to C. indica. In 2005, Hillig published a genetic analysis of the same set of accessions (this paper was the first in the series, but was delayed in publication), and proposed a three-species classification, recognizing C. sativa, C. indica, and (tentatively) C. ruderalis. In his doctoral dissertation published the same year, Hillig stated that principal components analysis of phenotypic (morphological) traits failed to differentiate the putative species, but that canonical variates analysis resulted in a high degree of discrimination of the putative species and infraspecific taxa. Another paper in the series on chemotaxonomic variation in the terpenoid content of the essential oil of Cannabis revealed that several wide-leaflet drug strains in the collection had relatively high levels of certain sesquiterpene alcohols, including guaiol and isomers of eudesmol, that set them apart from the other putative taxa. Hillig concluded that the patterns of genetic, morphological, and chemotaxonomic variation support recognition of C. sativa and C. indica as separate species. He also concluded there is little support to treat C. ruderalis as a separate species from C. sativa at this time, but more research on wild and weedy populations is needed because they were underrepresented in their collection.
While the other CBD oil stores have high-quality products, our choice simply came down to variety, potency and price. Whichever you choose to go for, though, know that all of the companies above have an outstanding store and offer a wide range of effective products, from CBD oils to Terps and even CBD creams. Plus, most have a 100% money back guarantee policy, which is quite nice!
2014 saw a flurry of interest in Cannabidiol in particular, with a slew of states successfully passing CBD only legislation after mounting pressure from many numbers of families with children suffering from intractable Epilepsy resulted in the fast tracking of Cannabidiol laws in more than 10 U.S. states. The Cannabidiol issue is proving to be quite popular politically as it allows politicians to get behind the "won't get you high" side of the CBD story while temporarily dancing around the looming issues of future medical marijuana programs that are pending or have been proposed in many of these states, as well as the national movement towards approval for medicinal and recreational use on a large scale.